How to appeal an Aetna bph procedures + medical therapy denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Aetna-specific note: Owned by CVS Health since 2018. CVS Caremark is the PBM. Aetna ASA administers self-funded ERISA plans. Meritain Health is Aetna's TPA brand.

What Aetna's policy requires for bph procedures + medical therapy

Cited policy: Aetna Clinical Policy Bulletin: Water Vapor Thermal Therapy (Rezum) for BPH

Age >=50 yr with LUTS attributed to BPH, IPSS >=13, prostate 30-80 cc, Qmax <15 mL/s, failed / intolerant of alpha-blocker therapy >=6 mo. May include obstructive median lobe per Rezum II protocol.

How Aetna denies bph procedures + medical therapy — and how to counter it

Where Aetna pushes back: 1) Investigational despite FDA Aug 2015 clearance; 2) Long-term durability unproven; 3) Insufficient medical-therapy trial; 4) Median-lobe exclusion.

Counter-arguments that hold up: Rezum FDA-cleared Aug 2015 (510(k)). Rezum II sham-controlled RCT McVary BJUI 2017 + 5-yr durability McVary J Urol 2021 — sustained IPSS reduction, ejaculation preserved, surgical retreatment ~4-5%. AUA BPH 2018 + 2023 amendment endorse Rezum for prostate 30-80 cc including median lobe. CPT 53854.

What Aetna typically denies for bph procedures + medical therapy

Across Aetna's commercial and Medicare books, denials cluster around a small number of patterns. For bph procedures + medical therapy, expect:

• UM-2575 medical necessity denials
• Prior auth absent
• Step therapy on specialty drugs
• Out-of-network ER reduction

Treatments most often denied in this category

These are the bph procedures + medical therapy treatments most often flagged for prior auth, step therapy, or medical necessity review:

• UroLift
• Rezum
• Aquablation
• iTind
• Optilume BPH
• GreenLight PVP

How to submit the appeal to Aetna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Aetna cited in the denial.
3. File the appeal through Aetna's portal (members: https://www.aetna.com ; providers: https://www.aetnaprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Aetna's prior-authorization criteria by drug: Aetna PA criteria on ApprovalHelp.